Breast Implants
Jul 16, 2026
POLYTECH Announced Regulatory Clearance for Improvements to the Microthane Process; ElectroWire Medical Earns 510(k) Clearance for LightningWire™ System; NeuroLexIQ Partners with Canary Speech to Introduce AI-Driven Voice Analysis for Injury Intake; BIOTRONIK Neuro Acquires Spinal Cord Stimulation Technology from Soin Neuroscience; Lakewood-Amedex Biotherapeutics Highlights Preclinical Safety Evidence Ahead of Nu-3 Gel Phase 2a Study; Cumulus Neuroscience Presents Evidence That Two-Minute Digital Test Enhances Alzheimer’s Trial Pre-enrichment
POLYTECH Announced the Approval of an Updated Process for Microthane® On 16 July 2026, POLYTECH Health & Aesthetics announced the approval of its updated proprietary manufacturing process for Microthane®, its polyurethane-coated breast implant technology. The company stated that the revised process was...
Read More...
Jan 23, 2025
Tempus Launches FDA-Approved xT CDx Test Nationwide; B. Braun Enhances Catheter Securement with the Launch of Clik-FIX; Illuccix® Secures European Regulatory Approval; FDA Clears CapsoCam Plus® for Remote Ingestion; BellaSeno Marks Success in Two Clinical Trials for Revolutionary Breast Implant Technology; AF Symposium to Feature Conformal Medical’s Groundbreaking GLACE Study
Tempus Announced the National Launch of the FDA-Approved xT CDx Test On January 15, 2025, Tempus AI, Inc., a technology company driving the use of AI to advance precision medicine and improve patient care, announced the nationwide launch of its FDA-approved, NGS-based in vitro diagnostic device, xT CDx. Th...
Read More...
Oct 03, 2024
Establishment Labs Gains FDA Approval for Motiva Implants; Surmodics Receives 510(k) Clearance for Pounce™ XL Thrombectomy System; Synergy Spine Solutions Completes Patient Enrollment in Synergy Disc® 2-Level IDE Clinical Trial; Medtronic Reports Strong Lesion Durability Data for PulseSelect™ Ablation System and Expands AiBLE™ Spine Surgery Ecosystem with Siemens Healthineers Partnership; Globus Medical Launches New Orthopedic Trauma Solutions
Establishment Labs Received U.S. FDA Approval for Motiva Implants On September 26, 2024, Establishment Labs Holdings Inc., a global medical technology company focused on enhancing women’s health and wellness, particularly in breast aesthetics and reconstruction, announced that it received approval from the U.S. ...
Read More...
Aug 22, 2024
Guard Medical Announced FDA 510(k) Clearance; PROCEPT BioRobotics Announced FDA Clearance; GE HealthCare Announced MASTER Trial Results; CollPlant and Stratasys Announced Pre-clinical Study; GE HealthCare Announced Collaboration to Investigate MRI Techniques; NOWDiagnostics’ Syphilis Test Received De Novo Marketing Authorization
Guard Medical Announced FDA 510(k) Clearance for Additional Large Sizes of its NPseal ® Surgical Dressing, Marking Product's Entry into the Orthopedic Market On August 19, 2024, Guard Medical, Inc., a medical technology company, announced FDA 510(k) clearance for expanded large sizes (up to 25cm) of its advanced...
Read More...
Jan 25, 2023
Aesthetic Implants Market : Evaluating the Major Factors Creating the Demand for Aesthetic Products
The idea of aesthetic implants or cosmetic surgery has always been a topic of conversation and debate in the healthcare market. Despite that, the demand for aesthetic implants has grown several folds over the past few years, especially among the younger generation, to enhance their physical appearance and to look m...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
